Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
66.05096
female
0
42
Coma
Coma
1
9
under $11k
94
146,193
null
null
33
white
24
45
0.148987
0.096985
7
0
0
no
null
null
dnr after sadm
1
120
48.5
125
18
36.09375
160
null
0.899902
1.799805
137
7.40918
85
19
2,560
null
0
adl>=4 (>=5 if sur)
0
493
0
52.98297
male
0
4
Lung Cancer
Cancer
0
18
>$50k
0
11,170
5,573.0039
4,493
12
white
17.398438
11
0.727905
0.455994
1
0
0
metastatic
0.9
0.8
no dnr
4
132
6.299805
110
11
36.39844
147.59375
3.099609
1.299805
4
128
7.319336
661
28
780
0
0
no(M2 and SIP pres)
0
493
0
52.01898
male
0
7
Lung Cancer
Cancer
1
15
$25-$50k
0
13,461
7,303.3203
4,927
10
white
3.299805
6
0.904907
0.780884
1
0
0
metastatic
0.9
0.8
no dnr
7
0
64.890625
0
0
32.89844
33
null
null
3.099609
132
7.149414
180
80
280
0
0
null
0
228
1
44.54999
male
0
8
CHF
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
11,776
null
null
10
black
15.099609
11
0.937988
0.894897
1
0
0
no
0.85
0.75
no dnr
8
75
9.199219
60
12
36.79688
188.5625
null
null
3.799805
130
7.479492
220
72
1,240
0
0
no(M2 and SIP pres)
0
493
0
63.88797
female
1
7
Cirrhosis
COPD/CHF/Cirrhosis
3
null
null
26
94,398
null
null
36
white
38.398438
65
0.096985
0.016998
14
0
0
no
0
0
dnr after sadm
6
72
7.5
110
26
36.5
361.875
3.299805
0.599976
0.399963
140
7.479492
126
1
2,675
null
null
<2 mo. follow-up
2.902832
7
1
66.56799
female
0
19
MOSF w/Malig
ARF/MOSF
1
16
>$50k
0
95,765
56,222.1875
64,797
22.666656
white
36.796875
63
0.231995
0.131989
23
0
0
yes
0.6
0.3
no dnr
19
57
5.199219
65
20
35.89844
null
null
2.599609
1.199951
122
null
64
22
4,290
null
1
<2 mo. follow-up
1
45
1
59.047
female
0
17
COPD
COPD/CHF/Cirrhosis
2
8
$25-$50k
0
35,298
23,559.5312
22,886
19
white
24.296875
27
0.845947
0.746948
1
0
0
no
0.6
0.5
no dnr
17
114
5.399414
69
24
36.5
324
3.299805
1.899902
1.5
141
7.529297
93
27
1,975
2
2
adl>=4 (>=5 if sur)
2
490
0
39.90399
female
0
55
MOSF w/Malig
ARF/MOSF
1
null
null
44
210,813
null
null
36.5
white
43
74
0.021999
0.004999
2
0
0
metastatic
0.1
0.02
dnr after sadm
2
105
25.199219
115
32
37.89844
97.95312
2.599609
0.5
1.5
147
7.419922
153
33
1,930
null
null
null
2.974121
490
0
63.82999
male
0
7
CHF
COPD/CHF/Cirrhosis
2
14
$25-$50k
0
15,924
null
null
10.5
white
11.099609
13
0.931885
0.884888
1
0
0
no
0.9
0.75
no dnr
7
70
36.195313
125
36
38.39844
137.75
2.599609
2.199707
2
158
7.459961
203
77
2,790
1
1
no(M2 and SIP pres)
1
490
0
67.25
male
0
8
COPD
COPD/CHF/Cirrhosis
1
16
$11-$25k
0
12,425
7,684.7969
7,854
13
white
21.699219
38
0.834961
0.72998
1
0
0
no
0.8
0.8
no dnr
8
106
10.5
119
28
37.89844
null
null
null
0.5
145
null
117
4
1,200
2
0
no(M2 and SIP pres)
0
488
0
66.12195
female
1
27
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
null
0
177,754
null
null
34.5
white
31
60
0.584961
0.474976
16
0
0
no
null
null
dnr after sadm
24
105
5.899414
110
32
36.69531
182.5
null
1.899902
0.699951
144
7.40918
373
20
3,795
null
0
<2 mo. follow-up
0
27
1
59.96698
male
1
7
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
8,896
6,078.3438
6,487
17.5
white
18.097656
24
0.891968
0.819946
1
1
0
no
0.7
0.5
dnr after sadm
3
48
20.296875
225
26
36.69531
262.8125
2.099609
47
2.299805
128
7.429688
46
47
2,305
null
0
<2 mo. follow-up
0
7
1
64.28497
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
7
under $11k
0
49,466
27,233.4844
30,352
25
black
18.699219
21
0.85498
0.804932
3
0
0
no
0.75
0.7
no dnr
11
52
13.699219
135
12
38.39844
142
null
7.799805
0.899902
150
7.549805
226
22
1,535
0
1
no(M2 and SIP pres)
1
487
0
61.50299
male
1
4
CHF
COPD/CHF/Cirrhosis
4
12
$25-$50k
0
11,292
null
null
15
white
71.1875
95
0
0
1
0
0
metastatic
0.1
0.3
dnr after sadm
1
62
10.199219
125
26
40.29688
228.5625
null
null
9.699219
139
7.319336
327
64
225
null
5
<2 mo. follow-up
5
4
1
71.737
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
under $11k
0
33,091
null
null
47
black
41.09375
81
0.327942
0.212982
3
1
0
no
0.65
0.6
dnr after sadm
3
95
4.599609
72
20
37.59375
null
3.299805
0.699951
0.899902
139
null
93
6
null
null
7
<2 mo. follow-up
7
5
1
71.19196
female
0
30
COPD
COPD/CHF/Cirrhosis
1
12
>$50k
0
61,413
null
null
13.25
white
23.699219
38
0.784912
0.654907
1
0
0
no
0.7
0.7
dnr after sadm
5
58
15.5
105
8
39.09375
227.5
null
4.699219
1.5
156
7.519531
49
50
2,365
0
null
null
0.494751
486
0
69.87799
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
3
under $11k
9
27,756
null
null
18
white
24.296875
36
0.759888
0.682983
1
0
0
no
0.5
0.5
no dnr
11
78
10.298828
75
6
36.39844
250
1.599854
null
3
148
7.40918
105
52
1,680
0
0
no(M2 and SIP pres)
0
166
1
78.85596
female
0
77
ARF/MOSF w/Sepsis
ARF/MOSF
0
7
under $11k
41
478,649
null
null
32.75
white
23.597656
43
0.488953
0.370972
46
0
0
no
0.3
0.3
dnr after sadm
68
128
12.5
75
44
38.5
371.625
null
null
1.099854
145
7.329102
387
34
1,840
null
0
Coma or Intub
0
89
1
45.60397
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
0
22,584
null
null
22.5
white
19.796875
16
0.900879
0.86499
1
0
0
no
0.9
0.9
no dnr
10
111
10
105
36
38.29688
384
null
1.5
0.699951
135
7.359375
185
8
2,950
null
0
null
0
484
0
48.91998
male
1
58
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
>$50k
0
482,255
null
null
47.25
white
32.195313
59
0.621948
0.517944
5
0
0
yes
0.8
0.8
no dnr
58
135
6.5
65
12
36.29688
326.625
null
null
0.799927
144
7.379883
93
5
2,425
1
null
<2 mo. follow-up
1.166748
58
1
66.086
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
61
112,648
null
null
36
white
35.296875
75
0.181976
0.093994
8
0
0
no
0.3
0.1
dnr after sadm
14
50
21.597656
135
31
39
147.5
null
0.699951
0.599976
142
7.429688
109
9
5,130
null
0
<2 mo. follow-up
0
25
1
70.09698
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
under $11k
0
22,644
null
null
16
white
17.597656
17
0.858887
0.809937
2
0
0
no
0.9
0.9
no dnr
13
73
10.599609
65
7
36.5
182.5
null
null
1.399902
138
7.489258
94
19
2,010
6
0
adl>=4 (>=5 if sur)
0
483
0
68.67596
male
0
63
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$11-$25k
41
131,874
null
null
40.25
white
47.796875
81
0.026997
0.007
1
0
0
yes
0.6
0.6
no dnr
63
78
5.599609
70
22
36.19531
null
null
null
2.399902
134
null
79
42
1,910
null
5
adl>=4 (>=5 if sur)
5
483
0
36.78598
male
0
33
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
$25-$50k
0
97,532
null
null
28
black
26.796875
52
0.822998
0.762939
6
0
0
no
0.5
0.5
no dnr
33
117
22.5
125
40
35.59375
165
null
null
3
131
7.389648
128
125
2,160
3
6
no(M2 and SIP pres)
6
482
0
85.41296
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$11-$25k
44
12,424
8,568.8906
10,477
18
white
25
23
0.523926
0.407959
1
0
1
no
0.6
0.6
dnr after sadm
1
143
13.298828
104
32
38.19531
490.4375
null
null
0.899902
133
7.379883
193
8
1,300
null
7
adl>=4 (>=5 if sur)
7
126
1
72.04395
male
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
null
0
100,393
null
null
23.25
white
23.699219
46
0.723999
0.638916
12
0
0
no
0.95
0.8
no dnr
25
140
26.597656
135
22
39.29688
75
null
null
1.599854
142
7.399414
97
25
1,005
0
0
no(M2 and SIP pres)
0
482
0
52.47598
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
94,485
null
null
58
white
42.695313
100
0.253967
0.149994
18
0
0
yes
0.4
0.35
dnr after sadm
4
125
12.898438
125
8
36.29688
172.5
null
null
1.899902
145
7.439453
286
19
4,385
null
null
<2 mo. follow-up
2.285645
5
1
59.34299
female
0
29
MOSF w/Malig
ARF/MOSF
2
18
null
0
null
null
null
36.75
white
35.695313
37
0.245972
0.142975
5
0
0
metastatic
0.8
0.3
null
null
77
0.399963
72
24
38.79688
null
null
0.899902
0.899902
138
null
107
4
null
null
2
<2 mo. follow-up
2
38
1
44.38898
female
0
114
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
9
256,454
null
null
42.75
white
19.898438
21
0.888916
0.849976
1
0
0
no
0.2
0.18
no dnr
114
58
8.898438
105
48
38.69531
231.40625
2.899902
0.899902
0.899902
131
7.479492
117
24
2,410
null
2
SIP>=30
2
479
0
65.82098
female
0
36
ARF/MOSF w/Sepsis
ARF/MOSF
0
17
$11-$25k
0
97,652
null
null
21.5
white
21.5
39
0.782959
0.711914
15
0
0
no
0.5
0.3
no dnr
36
75
1.5
104
20
36.5
466.625
2.099609
2.399902
0.799927
136
7.509766
143
8
1,050
null
7
no(M2 and SIP pres)
7
479
0
63.439
male
1
20
MOSF w/Malig
ARF/MOSF
2
null
null
44
101,509
null
null
35.666657
white
19.296875
36
0.632935
0.529907
1
0
0
yes
0.3
0.1
dnr after sadm
20
72
9.898438
75
28
36.19531
273.3125
4
1.199951
1.5
138
7.469727
90
40
2,790
null
0
<2 mo. follow-up
0
20
1
36.33398
female
0
5
Lung Cancer
Cancer
1
14
$25-$50k
0
11,640
5,957.5625
5,959
11
hispanic
15
13
0.800903
0.576904
1
0
0
metastatic
0.99
0.5
no dnr
5
135
14.298828
150
18
35.5
124
null
1.299805
1.599854
139
7.379883
344
64
960
0
0
no(M2 and SIP pres)
0
478
0
80.53894
male
1
17
ARF/MOSF w/Sepsis
ARF/MOSF
5
null
null
44
42,736
null
null
29.666656
white
26.199219
50
0.521973
0.405945
1
0
0
no
0.07
0.05
dnr after sadm
7
112
10.898438
75
28
38.69531
400
null
1.099854
0.799927
139
7.419922
138
12
2,095
null
null
<2 mo. follow-up
4.912109
17
1
40.84097
male
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
under $11k
0
82,428
null
null
21.25
white
29.097656
30
0.815918
0.754883
1
0
0
no
0.8
0.75
no dnr
26
83
11.798828
58
20
36.59375
null
null
6.099609
0.899902
138
null
93
11
1,000
1
1
SIP>=30
1
476
0
48.59097
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
$25-$50k
0
55,846
null
null
36
hispanic
34.695313
66
0.643921
0.542969
4
0
0
no
0.8
0.8
no dnr
15
118
10.398438
130
27
38.79688
185
null
24.898438
6.599609
138
7.429688
93
44
30
null
0
no(M2 and SIP pres)
0
477
0
71.00598
female
0
9
Lung Cancer
Cancer
3
12
under $11k
0
16,093
9,058
7,374
14.5
white
24.597656
7
0.506958
0.185974
1
1
0
metastatic
0.9
0.6
no dnr
9
99
9.898438
75
18
39
null
null
1
1.299805
140
null
119
26
1,200
4
6
adl>=4 (>=5 if sur)
6
114
1
62.92999
male
0
6
Lung Cancer
Cancer
1
17
>$50k
0
12,412
null
null
11
black
18.296875
10
0.685913
0.393982
1
0
0
metastatic
0.9
0.3
no dnr
6
118
17.597656
65
22
36.39844
null
3.199707
1
3.699707
135
null
60
87
2,525
0
0
no(M2 and SIP pres)
0
152
1
44.61298
male
0
6
Lung Cancer
Cancer
1
19
>$50k
0
12,011
null
null
7
white
15.298828
16
0.780884
0.541992
1
0
0
metastatic
0.8
0.6
no dnr
6
77
10.599609
95
28
38.29688
283.3125
2.099609
0.5
1.399902
137
7.419922
189
40
1,750
0
null
no(M2 and SIP pres)
0.494751
200
1
64.98596
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
under $11k
9
29,487
null
null
21
black
21
35
0.825928
0.766968
1
0
0
no
0.7
0.7
no dnr
13
33
19.199219
125
20
36.19531
230
1.599854
0.599976
4
136
7.439453
354
34
435
4
1
no(M2 and SIP pres)
1
475
0
68.92297
female
0
8
Lung Cancer
Cancer
2
12
under $11k
0
9,227
null
null
8.5
white
37.5
33
0.15097
0.008999
1
0
0
metastatic
0.7
0.5
no dnr
8
102
7.099609
120
38
35.39844
180
null
0.299988
0.5
142
7.489258
282
16
2,675
0
5
null
5
95
1
67.98596
male
0
9
Lung Cancer
Cancer
2
12
$11-$25k
0
8,297
null
null
10
white
14.5
14
0.747925
0.485962
1
0
0
metastatic
0.5
0.2
no dnr
9
122
11
115
8
38.09375
190
2.399902
1.299805
0.299988
138
7.619141
110
10
1,950
0
1
<2 mo. follow-up
1
10
1
37.97098
male
0
45
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
221,820
null
null
36.5
black
27.097656
23
0.81897
0.757935
5
0
0
no
0.6
0.6
dnr after sadm
18
133
4.5
110
28
38.5
323.75
null
1.5
0.699951
137
7.439453
66
10
2,835
null
4
no(M2 and SIP pres)
4
474
0
63.61099
female
0
12
COPD
COPD/CHF/Cirrhosis
2
null
null
26
33,089
null
null
27.5
white
23.597656
10
0.763916
0.625
1
0
0
no
0.75
0.7
no dnr
12
62
4.899414
105
20
35.39844
null
null
2.299805
1
137
null
89
18
4,600
null
0
no(M2 and SIP pres)
0
474
0
68.14496
male
0
5
Lung Cancer
Cancer
2
10
under $11k
9
4,951
3,143.1602
3,036
12
white
27.898438
23
0.375977
0.088989
1
0
0
metastatic
0.5
0.4
no dnr
5
58
7.099609
105
32
36.39844
96.65625
null
3.799805
1.099854
141
7.349609
106
34
1,555
null
0
no(M2 and SIP pres)
0
110
1
53.54099
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
5
10
under $11k
0
18,073
null
null
20
white
20
27
0.882935
0.841919
1
0
0
no
0.5
0.5
no dnr
9
144
11.099609
155
9
35.79688
344
null
null
0.5
135
7.439453
115
25
815
5
null
<2 mo. follow-up
3.854981
52
1
51.38699
male
0
44
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
37
223,362
null
null
31
white
19.199219
30
0.714966
0.628906
17
0
0
yes
null
null
no dnr
44
138
16.398438
105
25
38.19531
147.5
null
1.299805
1.199951
144
7.429688
364
40
1,933
null
null
null
2.817871
120
1
41.41299
male
0
9
Colon Cancer
Cancer
1
13
$11-$25k
0
12,398
null
null
11
white
12.398438
9
0.897949
0.766968
1
0
0
metastatic
null
null
no dnr
9
72
10.199219
75
26
36.19531
197.9375
null
1.099854
4
135
7.389648
153
36
480
1
1
no(M2 and SIP pres)
1
473
0
40.54498
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
null
9
25,414
null
null
21.5
black
23.898438
22
0.860962
0.81189
1
0
0
no
0.9
0.9
no dnr
10
161
26.699219
55
45
40.29688
260
null
null
0.699951
136
7.519531
159
20
3,180
0
null
SIP>=30
0.494751
472
0
74.81195
male
1
24
Coma
Coma
0
12
null
94
31,364
null
null
12.333328
white
15.898438
26
0.370972
0.297974
1
0
0
no
0.25
0.15
dnr after sadm
4
76
3.399902
68
16
36.5
null
3.299805
1
0.799927
138
null
101
4
3,850
null
0
<2 mo. follow-up
0
24
1
40.63199
male
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
4
14
$25-$50k
9
278,369
null
null
27.75
white
28.296875
50
0.791992
0.723999
2
1
0
no
0.95
0.95
no dnr
54
99
8.199219
72
20
36.89844
null
4.399414
0.599976
1
143
null
90
7
5,000
null
0
adl>=4 (>=5 if sur)
0
472
0
59.90399
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
$11-$25k
0
null
null
null
16.333328
white
25.597656
25
0.685913
0.592896
11
0
0
yes
0.75
0.5
null
null
78
5.399414
72
20
36
null
null
0.899902
1
140
null
79
14
2,000
3
1
no(M2 and SIP pres)
1
224
1
62.59
male
0
7
CHF
COPD/CHF/Cirrhosis
2
6
under $11k
0
12,107
null
null
11.5
white
17.398438
32
0.891968
0.819946
1
1
0
no
null
null
no dnr
7
46
11
75
38
39.09375
120
2.699707
4.899414
1.5
150
7.469727
169
29
1,920
0
null
no(M2 and SIP pres)
0.494751
471
0
47.89297
male
1
18
Coma
Coma
4
10
under $11k
9
71,025
null
null
43
black
23
52
0.784912
0.743896
1
1
0
no
0.6
0.6
no dnr
18
48
0.099991
65
28
35.59375
376.1875
2
0.5
0.599976
136
7.509766
173
22
3,050
3
0
<2 mo. follow-up
0
18
1
19.21399
female
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
38,076
null
null
13.666664
white
33.695313
42
0.823975
0.764893
1
0
0
no
0.9
0.9
no dnr
17
108
6.599609
115
6
36.29688
171.40625
null
0.699951
0.699951
134
7.30957
125
22
2,270
null
1
no(M2 and SIP pres)
1
469
0
71.79498
male
1
7
Lung Cancer
Cancer
1
null
null
37
8,297
null
null
10
white
35.09375
48
0.065994
0.001
1
0
0
metastatic
0.1
0.05
dnr after sadm
1
65
0.099991
135
40
38.59375
81.32812
null
null
0.399963
146
7.5
200
23
2,615
null
null
<2 mo. follow-up
2.985352
7
1
78.33295
female
0
6
CHF
COPD/CHF/Cirrhosis
2
8
null
0
7,350
null
null
17
white
16.097656
26
0.863892
0.775879
1
0
0
no
0.9
0.75
no dnr
6
97
11.699219
74
24
35.89844
null
4.5
0.799927
1.099854
135
null
65
12
1,400
null
null
no(M2 and SIP pres)
1.986084
468
0
38.75198
female
0
7
CHF
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
15,121
null
null
6
other
16.699219
12
0.937988
0.894897
1
0
0
no
null
null
no dnr
7
62
6
124
26
36.09375
288
null
0.799927
1.199951
137
7.389648
137
30
1,010
6
null
SIP>=30
4.527344
468
0
44.43799
female
0
9
Cirrhosis
COPD/CHF/Cirrhosis
2
9
under $11k
0
9,608
null
null
7.5
black
30.796875
44
0.702881
0.540894
1
0
0
no
0.7
0.6
no dnr
9
58
12.5
65
10
36
364
3.399902
2.699707
2.099609
128
7.329102
147
59
419
0
0
no(M2 and SIP pres)
0
468
0
69.08698
female
0
15
COPD
COPD/CHF/Cirrhosis
2
9
$25-$50k
0
14,097
null
null
10.333328
white
17.199219
15
0.843994
0.743896
1
0
0
yes
null
null
no dnr
15
67
10.298828
69
24
36.29688
268
null
1.399902
1.199951
132
7.479492
64
23
2,850
null
null
adl>=4 (>=5 if sur)
2.939941
70
1
67.737
female
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
3
7
under $11k
37
40,796
null
null
19.333328
black
24
49
0.681885
0.588989
1
1
0
no
0.5
0.4
no dnr
22
68
16.199219
75
40
38.79688
288.5625
null
null
1.399902
136
7.369141
125
12
3,475
null
7
adl>=4 (>=5 if sur)
7
467
0
53.771
female
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
110,603
null
null
22.75
white
27
37
0.802979
0.737915
1
0
0
no
null
null
no dnr
29
0
13
0
0
38
null
null
null
1.899902
133
null
295
133
350
null
1
no(M2 and SIP pres)
1
467
0
62.80899
male
0
18
Cirrhosis
COPD/CHF/Cirrhosis
3
18
under $11k
0
17,174
null
null
10.333328
white
17.898438
13
0.806885
0.687988
1
0
0
no
0.7
0.5
no dnr
18
45
15.898438
115
38
36
293.3125
null
1.599854
3.299805
145
7.319336
297
96
288
1
null
no(M2 and SIP pres)
1.166748
125
1
58.15997
male
1
8
Lung Cancer
Cancer
1
null
null
0
null
null
null
13
black
25.199219
38
0.533936
0.210999
1
0
0
metastatic
0.1
0.05
null
null
95
9.099609
160
26
36.09375
359.25
null
0.699951
0.699951
135
7.509766
137
17
7,160
null
null
<2 mo. follow-up
2.352051
8
1
54.34097
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
null
44
22,928
null
null
37
white
45.59375
91
0.106995
0.044998
4
0
0
no
null
null
dnr after sadm
3
108
18.898438
140
12
36.19531
322.1875
2.599609
0.599976
0.799927
141
7.439453
90
22
1,790
null
6
<2 mo. follow-up
6
4
1
78.44495
female
1
27
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
under $11k
0
137,050
null
null
19.75
white
20.796875
37
0.669922
0.573975
47
1
0
yes
0.5
0.5
dnr after sadm
27
65
6.599609
65
42
38.69531
280
null
0.899902
3.399902
136
7.40918
206
134
2,020
null
1
<2 mo. follow-up
1
27
1
64.78296
female
1
18
ARF/MOSF w/Sepsis
ARF/MOSF
3
6
under $11k
0
156,244
null
null
51
black
31.699219
50
0.60791
0.501953
6
1
0
no
null
null
dnr after sadm
17
107
10
65
28
36.09375
280
2.599609
0.299988
0.599976
135
7.40918
97
8
7,175
null
3
<2 mo. follow-up
3
18
1
68.99097
male
0
11
CHF
COPD/CHF/Cirrhosis
3
2
null
0
15,076
null
null
17
black
19.097656
35
0.859985
0.767944
1
0
0
no
null
null
no dnr
11
159
11.699219
50
10
36.79688
197.125
null
10.798828
1.399902
153
7.469727
155
42
1,595
0
0
no(M2 and SIP pres)
0
466
0
59.69098
male
0
9
Lung Cancer
Cancer
1
12
$25-$50k
0
12,240
null
null
12.5
white
12.599609
16
0.794922
0.565918
1
0
0
metastatic
0.9
0.8
no dnr
9
125
15.599609
125
40
38.39844
154.28125
1.799805
21
1.099854
142
7.389648
204
21
1,470
0
0
null
0
175
1
58.94897
male
0
5
Lung Cancer
Cancer
1
22
>$50k
0
11,230
null
null
13
white
14.298828
13
0.769897
0.522949
1
0
0
metastatic
0.8
0.6
no dnr
5
78
10.099609
75
25
36.09375
356.625
2.799805
0.699951
0.799927
141
7.40918
91
18
2,040
null
0
null
0
231
1
71.69897
female
1
21
CHF
COPD/CHF/Cirrhosis
5
11
under $11k
0
19,356
null
null
11
white
21.699219
25
0.820923
0.707886
1
1
0
no
0.7
0.6
dnr after sadm
6
45
14.099609
110
10
35.59375
87.14062
1.299805
1.699951
4.099609
143
7.449219
267
114
655
5
null
<2 mo. follow-up
3.854981
21
1
51.47198
male
1
12
Cirrhosis
COPD/CHF/Cirrhosis
3
14
>$50k
0
90,014
null
null
42
white
27.296875
31
0.720947
0.564941
1
0
0
no
null
null
dnr after sadm
12
68
15.199219
105
27
36.69531
225.6875
null
1.699951
7.399414
135
7.40918
139
79
169
null
1
<2 mo. follow-up
1
12
1
83.70197
female
1
3
Coma
Coma
0
null
null
100
44,537
null
null
36
white
64.5
103
0
0
11
0
0
no
null
null
dnr after sadm
3
122
15.298828
88
28
36.09375
148.3125
2.599609
0.5
0.599976
141
7.429688
134
18
975
null
null
<2 mo. follow-up
2.325684
3
1
56.70099
male
0
6
Lung Cancer
Cancer
2
11
null
9
8,106
null
null
8
white
24.199219
26
0.521973
0.199982
1
0
0
metastatic
0.3
0.1
dnr before sadm
0
58
15.398438
60
12
36
292
null
1.599854
1.099854
133
7.479492
99
42
1,640
null
3
<2 mo. follow-up
3
9
1
49.39899
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
>$50k
0
62,140
null
null
28.666656
white
21.398438
34
0.878906
0.836914
1
0
0
no
0.98
0.9
no dnr
18
43
25.296875
165
14
37.89844
150
1.5
1.399902
3.5
145
7.379883
227
40
145
null
0
no(M2 and SIP pres)
0
462
0
77.32794
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
5
under $11k
9
48,687
null
null
19
black
26
58
0.659912
0.56189
3
0
0
no
0.3
0.2
no dnr
15
112
2.5
135
10
36.39844
133.3125
2.599609
null
1.299805
129
7.349609
154
41
2,235
null
1
no(M2 and SIP pres)
1
462
0
70.65796
male
0
39
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
91,132
null
null
23
black
23.398438
30
0.795898
0.72998
1
1
0
no
0.8
0.7
no dnr
39
63
13.699219
65
8
36.09375
373.3125
null
1
0.599976
138
7.449219
192
65
2,480
1
2
no(M2 and SIP pres)
2
268
1
51.01199
female
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
null
55
83,982
null
null
32.5
asian
22.796875
21
0.689941
0.596924
3
0
0
no
0.5
0.4
no dnr
54
122
18
105
24
36.5
213.3125
2.099609
1.299805
1.5
140
7.469727
145
45
2,900
null
0
null
0
430
1
39.67099
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
null
0
88,980
null
null
30
white
22.199219
57
0.862915
0.815918
8
1
0
no
0.5
0.5
no dnr
19
112
63.5
65
24
38.59375
185
3.299805
0.899902
1
148
7.469727
343
30
2,910
null
4
no(M2 and SIP pres)
4
461
0
77.07599
male
0
4
CHF
COPD/CHF/Cirrhosis
3
3
null
0
5,846
null
null
6
black
21.296875
28
0.804932
0.684937
1
1
0
no
null
null
no dnr
4
60
3.899902
68
20
37.09375
null
null
null
0.699951
139
null
88
4
4,400
null
0
no(M2 and SIP pres)
0
461
0
57.06998
female
0
26
Lung Cancer
Cancer
1
12
$25-$50k
0
40,442
null
null
11
white
17.398438
14
0.718994
0.441956
1
0
0
metastatic
null
null
no dnr
26
135
12.898438
115
36
38.19531
305
null
0.5
6.199219
139
7.369141
158
101
960
0
0
<2 mo. follow-up
0
29
1
54.20398
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
6
$25-$50k
9
88,300
null
null
18.666656
white
22.597656
21
0.79895
0.731934
7
0
0
no
0.98
0.96
no dnr
19
102
33.09375
105
24
36.39844
196.65625
null
null
3.5
146
7.419922
122
35
4,140
null
0
no(M2 and SIP pres)
0
460
0
73.07599
male
0
7
Colon Cancer
Cancer
2
16
$11-$25k
0
13,001
null
null
10.5
white
21.898438
15
0.718994
0.441956
1
1
0
metastatic
0.9
0.8
no dnr
7
125
11.898438
120
10
35.39844
145
null
0.5
9
131
7.399414
223
99
170
0
0
no(M2 and SIP pres)
0
220
1
66.86694
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
7
$25-$50k
9
57,345
null
null
32.666657
white
24
19
0.740967
0.660889
4
0
0
no
null
null
no dnr
15
81
10
62
22
36.39844
null
2.899902
0.599976
0.699951
134
null
168
4
2,800
null
0
adl>=4 (>=5 if sur)
0
459
0
25.95999
male
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
161,427
null
null
35
black
31.597656
51
0.774902
0.702881
14
0
0
no
null
null
no dnr
24
103
null
80
20
36.29688
null
3.099609
0.299988
0.899902
139
null
129
9
4,150
null
null
null
2.467773
459
0
59.53699
male
0
12
Colon Cancer
Cancer
1
18
null
0
32,064
null
null
15.5
white
16.898438
9
0.827881
0.625977
1
0
0
metastatic
null
null
no dnr
12
71
9.5
112
24
37.59375
null
3.699707
0.5
0.799927
142
null
80
6
null
null
0
no(M2 and SIP pres)
0
459
0
56.00299
female
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
170,509
null
null
19.75
white
29.5
66
0.662964
0.564941
43
0
0
no
0.5
0.2
dnr after sadm
1
110
6.599609
115
30
36.79688
330
3.799805
1.399902
0.899902
141
7.40918
403
20
2,300
null
3
no(M2 and SIP pres)
3
266
1
75.14899
male
0
5
Coma
Coma
2
null
null
44
28,049
null
null
22
white
17.597656
18
0.409973
0.335999
6
1
0
yes
0.5
0.1
dnr after sadm
3
94
1.5
118
32
35.5
null
2.599609
2.299805
0.399963
143
null
87
19
2,700
null
null
<2 mo. follow-up
2.07666
9
1
68.54797
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
91,794
null
null
29.666656
white
25
43
0.751953
0.67395
3
1
0
no
0.95
0.9
dnr after sadm
6
67
6.399414
82
20
36.69531
null
null
0.599976
1.399902
136
null
66
18
null
null
0
no(M2 and SIP pres)
0
457
0
37.12
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
$11-$25k
44
201,047
null
null
48
white
45.59375
93
0.140991
0.065994
30
0
0
no
null
null
dnr after sadm
5
125
5
105
12
38.79688
125
null
null
1.299805
150
7.429688
80
33
2,635
null
0
<2 mo. follow-up
0
5
1
62.66098
male
0
4
Lung Cancer
Cancer
2
15
>$50k
0
11,150
null
null
14
white
8.099609
12
0.849976
0.667969
1
0
0
metastatic
0.6
0.4
no dnr
4
95
14.699219
60
10
37
174.28125
null
0.699951
0.699951
130
7.589844
118
12
3,702
0
0
no(M2 and SIP pres)
0
192
1
60.54797
male
0
12
Coma
Coma
0
12
$11-$25k
44
49,329
null
null
38.5
white
25.699219
30
0.488953
0.416992
1
0
0
no
null
null
no dnr
12
102
12.398438
100
16
35.69531
376.1875
2.899902
0.399963
1.599854
142
7.419922
117
31
null
null
1
<2 mo. follow-up
1
14
1
38.66898
female
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
48,615
null
null
23
black
27.597656
33
0.840942
0.786987
1
0
0
no
0.9
0.9
no dnr
18
80
10.699219
120
24
38.19531
300
2.099609
null
0.699951
143
7.439453
123
18
860
0
1
no(M2 and SIP pres)
1
456
0
91.27698
female
0
6
COPD
COPD/CHF/Cirrhosis
2
12
null
0
6,053
null
null
12
white
17.296875
22
0.748901
0.603882
1
0
0
no
0.9
0.9
no dnr
6
107
7.299805
105
32
38.5
263.3125
2
null
0.699951
133
7.449219
343
17
4,880
null
1
adl>=4 (>=5 if sur)
1
95
1
60.93597
female
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
9
106,360
null
null
27.25
black
27.5
37
0.740967
0.659912
1
1
0
no
null
null
no dnr
40
100
5.599609
75
20
38
null
null
null
0.899902
140
null
97
6
2,450
null
1
no(M2 and SIP pres)
1
454
0
46.52399
female
1
10
MOSF w/Malig
ARF/MOSF
1
null
null
9
91,630
null
null
41
white
38.5
54
0.198975
0.106995
11
0
0
yes
0.6
0.2
dnr after sadm
9
133
5.899414
115
10
38.59375
145
null
1
1.199951
141
7.439453
94
15
2,290
null
null
<2 mo. follow-up
2.117676
10
1
77.80396
male
0
9
Cirrhosis
COPD/CHF/Cirrhosis
2
12
under $11k
0
9,589
null
null
10.5
white
19.597656
33
0.677979
0.507935
1
0
0
no
0.5
0.3
no dnr
9
115
13.599609
75
14
36.69531
511
null
null
0.899902
135
7.379883
131
20
1,100
null
0
<2 mo. follow-up
0
51
1
64.08197
female
1
148
ARF/MOSF w/Sepsis
ARF/MOSF
2
6
null
0
526,585
null
null
36.75
white
35
39
0.404968
0.28595
15
0
0
yes
0.75
0.7
dnr after sadm
35
128
13
115
8
36.39844
376.625
null
null
7.299805
136
7.299805
100
86
1,138
null
0
adl>=4 (>=5 if sur)
0
148
1
61.25897
male
0
7
Lung Cancer
Cancer
1
14
>$50k
0
6,386
null
null
5
white
13.898438
5
0.771973
0.526978
1
0
0
metastatic
0.6
0.1
no dnr
7
137
2.299805
120
24
38.09375
270
null
0.699951
0.599976
137
7.469727
121
13
5,250
null
0
null
0
70
1
72.25696
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
9
57,475
null
null
27.5
white
22.296875
48
0.748901
0.668945
4
0
0
no
0.88
0.85
no dnr
9
133
7.399414
75
28
37.5
null
null
null
1.899902
139
null
95
24
5,200
0
0
no(M2 and SIP pres)
0
451
0
74.23096
male
1
19
MOSF w/Malig
ARF/MOSF
1
16
>$50k
37
175,130
null
null
45
white
44
97
0.007999
0.001
42
0
0
yes
0.2
0.15
dnr after sadm
3
75
13.898438
65
13
36.5
344
3.399902
1.399902
8.199219
138
7.379883
193
66
0
null
0
<2 mo. follow-up
0
19
1